Aristotle
Topics
Medicine
Clinical evidence, therapeutics pipelines and health system delivery.
Following
Latest developments
GLP-1 cardiovascular outcomes trial reports at 36 months
Journal · 1 day ago
Evidence
Important papers
Incretin therapy and cardiovascular risk
NEJM · 2025
Saved knowledge
Artificial General Intelligence
GLP-1 receptor agonists
Sovereign compute
Home
Research
Knowledge
Library
Profile
a
r
i
s
t
o
t
l
e
Skip